{"url_path":"/sec/qlep/8-k/2026-07-08/item-8-01","section_key":"item-8-01","section_title":"Item 8.01 Other Events.**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-07-08","source_url":"https://www.sec.gov/Archives/edgar/data/2102155/0001213900-26-076355-index.html","accession_number":"0001213900-26-076355","cik":"0002102155","ticker":"QLEP","issuer_name":"Quantum Leap Acquisition Corp","edgar_url":"https://www.sec.gov/Archives/edgar/data/2102155/0001213900-26-076355-index.html","primary_entity_key":"0002102155","primary_entity_name":"Quantum Leap Acquisition Corp"},"word_count":491,"has_tables":true,"body_markdown":"**Item 8.01. Other Events.**\n\n \n\nAs\npreviously reported, on May 4, 2026, Quantum Leap Acquisition Corp (the “Company”) consummated its initial public offering (“IPO”)\nof 20,000,000 units (the “Units”) at a price of $10.00 per Unit. Each Unit consists of one Class A ordinary share of the Company,\npar value $0.0001 per share (the “Class A Ordinary Shares”), and one redeemable warrant (each, a “Warrant”). In connection\nwith the IPO, the Company granted the underwriter a 45-day option to purchase up to an additional 3,000,000 Units at the initial public\noffering price to cover over-allotments, if any.\n\n \n\nAs\npreviously reported, on May 8, 2026, the underwriter notified the Company of its partial exercise of the over-allotment option to purchase\nan additional 917,392 Units, which closed on May 12, 2026.\n\n \n\nOn\nJune 18, 2026, the underwriter notified the Company of its exercise of the remaining portion of the over-allotment option to purchase\nan additional 2,082,608 Units at $10.00 per Unit, generating additional gross proceeds to the Company of $20,826,080. The exercise of\nthe remaining over-allotment option closed on June 22, 2026, and, as a result, the underwriter has exercised its over-allotment option\nin full for an aggregate of 3,000,000 Units.\n\n \n\nSimultaneously\nwith the closing of the remaining exercise of the over-allotment option which closed on June 22, 2026, and pursuant to that certain Private\nPlacement Units Purchase Agreement, dated as of May 4, 2026, by and between the Company and Paddington Partners 88 LLC (the “Sponsor”),\nthe Sponsor agreed to purchase an additional 43,946 private placement units (the “Private Placement Units”) at a price of $10.00\nper Private Placement Unit, for an aggregate purchase price of $439,460. The Private Placement Units (and underlying securities) are identical\nto the Units sold in the IPO, except as otherwise disclosed in the Registration Statement. No underwriting discounts or commissions were\npaid with respect to the sale of the Private Placement Units. The issuance of the Private Placement Units was made pursuant to the exemption\nfrom registration contained in Section 4(a)(2) of the Securities Act of 1933, as amended.\n\n \n\nFollowing\nthe closing of the remaining exercise of the over-allotment option, as is more particularly described in the audited balance sheet, an\naggregate of $233,146,313 is held in the Company’s U.S.-based trust account maintained by Continental Stock Transfer & Trust Company,\nacting as trustee.\n\n \n\nOn\nJune 23, 2026, the Class A Ordinary Shares and Warrants comprising the Units commenced separate trading on the New York Stock Exchange\nunder the symbols “QLEP” and “QLEP WS,” respectively. At such time, holders ceased to hold Units, the Units ceased\nto trade, and the Units are no longer listed on the New York Stock Exchange.\n\n \n\nAn audited balance sheet\nas of June 22, 2026 reflecting the receipt of the proceeds from the IPO, the Private Placement and the exercise of the over-allotment\noption has been issued by the Company and is included as Exhibit 99.1 to this Current Report on Form 8-K"}